Get the app
US › Healthcare

Silo Pharma Inc (SILO)

US · Healthcare · Biotechnology

$1.33+3.10%
Last close · 2026-11-06

Latest quarter · ended 2026-06-30

Revenue
$0
Revenue YoY
-100.0%
Net profit
$-832,829
EPS
$-0.76

Key statistics

Market cap
$2.8M
Forward P/E
0.0
P/B
0.58
Book value
$4.33
EPS (TTM)
$-4.26
52-week high
$10.43
52-week low
$1.10
50-day MA
$1.68
200-day MA
$4.50
Beta
0.91

Analyst view

with an average price target of $10.00.

Shareholding

Insiders
8.17%
Institutions
5.80%

Largest institutional holders

FundStake
AdvisorShares Investments, LLC3.68%
Citadel Advisors Llc0.82%
Vanguard Capital Management, LLC0.58%
Vanguard Fiduciary Trust Co0.04%
Tower Research Capital LLC0.01%
IFP Advisors, LLC0.01%
HARBOUR INVESTMENTS, INC.0.00%
Citigroup Inc0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Silo Pharma Inc — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-11-07.